Industry litigation – Page 17
-
BusinessUS poised to approve its first ‘biosimilar’ drug
FDA panel recommends Sandoz’s copy of Amgen’s Neupogen
-
-
Business
EU recommends Parkinson’s drug for approval
First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials
-
Business
EU chemicals regulator scolded over animal testing
Ombudsman says ECHA isn’t doing enough to require alternative, non-animal methods
-
Business
Consumer products firms fined for French price fixing
€950m fines for ‘friends clubs’ that pushed up prices for home and personal care products
-
Business
Freedom Industries’ president arrested for fraud
Executive whose company leaked MCHM into West Virginian water supplies is charged with lying to deflect blame
-
Business
Big pharma opens up abandoned drugs
Seven firms will make 68 stalled compounds available for academic research
-
Business
DuPont quantifies scale of deadly chemical leak
10.4 tonnes of methyl mercaptan were released in La Porte, US
-
Business
Ranbaxy sues over withdrawn US approvals
Company says decision is ‘unconstitutional’ and deprives it of hundreds of millions of dollars in revenue
-
BusinessMethyl mercaptan leak kills four workers
Cause of accident at US DuPont plant is still under investigation
-
Business
EU warns DuPont and Honeywell over green refrigerants
Commission thinks cooperation may have been anti-competitive
-
Business
Judge slashes fines in drug safety case
Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million
-
Business
Amgen seeks injunction to protect patents
Sanofi and Regeneron sued over cholesterol-regulating antibodies
-
BusinessIndian manufacturers hit back over quality claims
Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers
-
Business
US tax changes ripple into merger deals
Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave
-
Business
Dow’s $1bn price-fixing fine upheld
Firm loses its appeal against damages for fixing polyurethane prices
-
-
Business
Gilead licenses generic hepatitis C drug in India
Company aims to head off competition and grab a slice of royalties
-
Business
US drops restrictions on more GM seeds
Dow’s herbicide-resistant corn and soybeans spark renewed criticism from environmental campaigners
-
BusinessBP faces $18bn fine over Deepwater
US judge rules that BP’s recklessness caused blowout through ‘gross negligence or willful misconduct’, but the firm will appeal